MedTech Dive May 16, 2024
Diabetes tech companies shared updates on new products, largely focused on Type 2 patients, in Q1 earnings calls.
Dexcom shared more details about its plans to sell an over-the-counter continuous glucose monitor this summer. The device, called Stelo, is intended for people with diabetes who don’t take insulin.
Stelo is one of several planned launches this year by diabetes technology companies focused on Type 2 diabetes, amid a coverage expansion by insurers. Last year, Medicare began covering CGMs for all people with diabetes who take insulin or have a history of hypoglycemia, removing a coverage requirement that people must take multiple daily doses of insulin.
Diabetes tech companies outlined their plans for upcoming products in first-quarter earnings calls and reaffirmed...
Today's Sponsors
Today's Sponsor